VEGFR2 Recombinant Antibody, Biotin Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-63075r-biotin-100uL |
| Product Name | VEGFR2 Recombinant Antibody, Biotin Conjugated |
| Applications |
IHC-P
IHC-F
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Biotin |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human VEGFR2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 3791 |
| Swiss Prot | P35968 |
| Subcellular location | Cytoplasm, Nucleus, Secreted, Cell membrane |
| Synonyms | Vascular endothelial growth factor receptor 2; KDR; VEGF Receptor 2; CD309; CD309 antigen; Fetal liver kinase 1; FLK-1; FLK1; Kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Protein-tyrosine kinase receptor flk-1; Tyrosine kinase growth factor receptor; VEGFR 2; VEGFR; VEGFR-2; VGFR2_HUMAN. |
| Application Dilution | |
| IHC-P | IF1:100-500 |
| IHC-F | IHC-F1:100-500 |
Frequently asked questions
Which applications is VEGFR2 Recombinant Antibody, Biotin Conjugated (bsm-63075R-Biotin) validated for, and at what dilution?
bsm-63075R-Biotin is validated for IHC-P(IF(IHC-P)) (1:100-500); IHC-F(IHC-F) (1:100-500). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does VEGFR2 Recombinant Antibody, Biotin Conjugated (bsm-63075R-Biotin) react with?
Tested reactivity: Human.
How should bsm-63075R-Biotin be stored?
Store at -20°C for 12 months. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise VEGFR2 Recombinant Antibody, Biotin Conjugated (bsm-63075R-Biotin)?
KLH conjugated synthetic peptide derived from human VEGFR2